The global Drugs for Central Nervous System market was valued at US$ 108710 million in 2023 and is projected to reach US$ 180090 million by 2030, at a CAGR of 7.9% during the forecast period.
This research report provides a comprehensive analysis of the Drugs for Central Nervous System market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Drugs for Central Nervous System market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Drugs for Central Nervous System, challenges faced by the industry, and potential opportunities for market players.
The global Drugs for Central Nervous System market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Drugs for Central Nervous System market presents opportunities for various stakeholders, including Hospital, Retail Pharmacy. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Drugs for Central Nervous System market. Additionally, the growing consumer demand present avenues for market expansion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Drugs for Central Nervous System market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Drugs for Central Nervous System market.
Market Overview: The report provides a comprehensive overview of the Drugs for Central Nervous System market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., OTC, Rx Drugs), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Drugs for Central Nervous System market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Drugs for Central Nervous System market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Drugs for Central Nervous System market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Drugs for Central Nervous System market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Drugs for Central Nervous System market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Drugs for Central Nervous System market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Drugs for Central Nervous System, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Drugs for Central Nervous System market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
- Drugs for Central Nervous System market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Market segment by Application
Global Drugs for Central Nervous System Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- Biogen
- Pfizer
- Teva
- Novartis
- Johnson & Johnson
- EliLilly
- Otsuka
- Merck
- AstraZeneca
- Novartis
- Takeda
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs for Central Nervous System, market overview.
Chapter 2: Global Drugs for Central Nervous System market size in revenue and volume.
Chapter 3: Detailed analysis of Drugs for Central Nervous System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs for Central Nervous System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Drugs for Central Nervous System capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Drugs for Central Nervous System Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Central Nervous System Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Central Nervous System Overall Market Size
2.1 Global Drugs for Central Nervous System Market Size: 2023 VS 2030
2.2 Global Drugs for Central Nervous System Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Drugs for Central Nervous System Sales: 2019-2030
3 Company Landscape
3.1 Top Drugs for Central Nervous System Players in Global Market
3.2 Top Global Drugs for Central Nervous System Companies Ranked by Revenue
3.3 Global Drugs for Central Nervous System Revenue by Companies
3.4 Global Drugs for Central Nervous System Sales by Companies
3.5 Global Drugs for Central Nervous System Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Drugs for Central Nervous System Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Drugs for Central Nervous System Product Type
3.8 Tier 1, Tier 2 and Tier 3 Drugs for Central Nervous System Players in Global Market
3.8.1 List of Global Tier 1 Drugs for Central Nervous System Companies
3.8.2 List of Global Tier 2 and Tier 3 Drugs for Central Nervous System Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Drugs for Central Nervous System Market Size Markets, 2023 & 2030
4.1.2 OTC
4.1.3 Rx Drugs
4.2 By Type - Global Drugs for Central Nervous System Revenue & Forecasts
4.2.1 By Type - Global Drugs for Central Nervous System Revenue, 2019-2024
4.2.2 By Type - Global Drugs for Central Nervous System Revenue, 2025-2030
4.2.3 By Type - Global Drugs for Central Nervous System Revenue Market Share, 2019-2030
4.3 By Type - Global Drugs for Central Nervous System Sales & Forecasts
4.3.1 By Type - Global Drugs for Central Nervous System Sales, 2019-2024
4.3.2 By Type - Global Drugs for Central Nervous System Sales, 2025-2030
4.3.3 By Type - Global Drugs for Central Nervous System Sales Market Share, 2019-2030
4.4 By Type - Global Drugs for Central Nervous System Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Drugs for Central Nervous System Market Size, 2023 & 2030
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.2 By Application - Global Drugs for Central Nervous System Revenue & Forecasts
5.2.1 By Application - Global Drugs for Central Nervous System Revenue, 2019-2024
5.2.2 By Application - Global Drugs for Central Nervous System Revenue, 2025-2030
5.2.3 By Application - Global Drugs for Central Nervous System Revenue Market Share, 2019-2030
5.3 By Application - Global Drugs for Central Nervous System Sales & Forecasts
5.3.1 By Application - Global Drugs for Central Nervous System Sales, 2019-2024
5.3.2 By Application - Global Drugs for Central Nervous System Sales, 2025-2030
5.3.3 By Application - Global Drugs for Central Nervous System Sales Market Share, 2019-2030
5.4 By Application - Global Drugs for Central Nervous System Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Drugs for Central Nervous System Market Size, 2023 & 2030
6.2 By Region - Global Drugs for Central Nervous System Revenue & Forecasts
6.2.1 By Region - Global Drugs for Central Nervous System Revenue, 2019-2024
6.2.2 By Region - Global Drugs for Central Nervous System Revenue, 2025-2030
6.2.3 By Region - Global Drugs for Central Nervous System Revenue Market Share, 2019-2030
6.3 By Region - Global Drugs for Central Nervous System Sales & Forecasts
6.3.1 By Region - Global Drugs for Central Nervous System Sales, 2019-2024
6.3.2 By Region - Global Drugs for Central Nervous System Sales, 2025-2030
6.3.3 By Region - Global Drugs for Central Nervous System Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Drugs for Central Nervous System Revenue, 2019-2030
6.4.2 By Country - North America Drugs for Central Nervous System Sales, 2019-2030
6.4.3 US Drugs for Central Nervous System Market Size, 2019-2030
6.4.4 Canada Drugs for Central Nervous System Market Size, 2019-2030
6.4.5 Mexico Drugs for Central Nervous System Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Drugs for Central Nervous System Revenue, 2019-2030
6.5.2 By Country - Europe Drugs for Central Nervous System Sales, 2019-2030
6.5.3 Germany Drugs for Central Nervous System Market Size, 2019-2030
6.5.4 France Drugs for Central Nervous System Market Size, 2019-2030
6.5.5 U.K. Drugs for Central Nervous System Market Size, 2019-2030
6.5.6 Italy Drugs for Central Nervous System Market Size, 2019-2030
6.5.7 Russia Drugs for Central Nervous System Market Size, 2019-2030
6.5.8 Nordic Countries Drugs for Central Nervous System Market Size, 2019-2030
6.5.9 Benelux Drugs for Central Nervous System Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Drugs for Central Nervous System Revenue, 2019-2030
6.6.2 By Region - Asia Drugs for Central Nervous System Sales, 2019-2030
6.6.3 China Drugs for Central Nervous System Market Size, 2019-2030
6.6.4 Japan Drugs for Central Nervous System Market Size, 2019-2030
6.6.5 South Korea Drugs for Central Nervous System Market Size, 2019-2030
6.6.6 Southeast Asia Drugs for Central Nervous System Market Size, 2019-2030
6.6.7 India Drugs for Central Nervous System Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Drugs for Central Nervous System Revenue, 2019-2030
6.7.2 By Country - South America Drugs for Central Nervous System Sales, 2019-2030
6.7.3 Brazil Drugs for Central Nervous System Market Size, 2019-2030
6.7.4 Argentina Drugs for Central Nervous System Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Drugs for Central Nervous System Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Drugs for Central Nervous System Sales, 2019-2030
6.8.3 Turkey Drugs for Central Nervous System Market Size, 2019-2030
6.8.4 Israel Drugs for Central Nervous System Market Size, 2019-2030
6.8.5 Saudi Arabia Drugs for Central Nervous System Market Size, 2019-2030
6.8.6 UAE Drugs for Central Nervous System Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 Biogen
7.1.1 Biogen Company Summary
7.1.2 Biogen Business Overview
7.1.3 Biogen Drugs for Central Nervous System Major Product Offerings
7.1.4 Biogen Drugs for Central Nervous System Sales and Revenue in Global (2019-2024)
7.1.5 Biogen Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Drugs for Central Nervous System Major Product Offerings
7.2.4 Pfizer Drugs for Central Nervous System Sales and Revenue in Global (2019-2024)
7.2.5 Pfizer Key News & Latest Developments
7.3 Teva
7.3.1 Teva Company Summary
7.3.2 Teva Business Overview
7.3.3 Teva Drugs for Central Nervous System Major Product Offerings
7.3.4 Teva Drugs for Central Nervous System Sales and Revenue in Global (2019-2024)
7.3.5 Teva Key News & Latest Developments
7.4 Novartis
7.4.1 Novartis Company Summary
7.4.2 Novartis Business Overview
7.4.3 Novartis Drugs for Central Nervous System Major Product Offerings
7.4.4 Novartis Drugs for Central Nervous System Sales and Revenue in Global (2019-2024)
7.4.5 Novartis Key News & Latest Developments
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Summary
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Drugs for Central Nervous System Major Product Offerings
7.5.4 Johnson & Johnson Drugs for Central Nervous System Sales and Revenue in Global (2019-2024)
7.5.5 Johnson & Johnson Key News & Latest Developments
7.6 EliLilly
7.6.1 EliLilly Company Summary
7.6.2 EliLilly Business Overview
7.6.3 EliLilly Drugs for Central Nervous System Major Product Offerings
7.6.4 EliLilly Drugs for Central Nervous System Sales and Revenue in Global (2019-2024)
7.6.5 EliLilly Key News & Latest Developments
7.7 Otsuka
7.7.1 Otsuka Company Summary
7.7.2 Otsuka Business Overview
7.7.3 Otsuka Drugs for Central Nervous System Major Product Offerings
7.7.4 Otsuka Drugs for Central Nervous System Sales and Revenue in Global (2019-2024)
7.7.5 Otsuka Key News & Latest Developments
7.8 Merck
7.8.1 Merck Company Summary
7.8.2 Merck Business Overview
7.8.3 Merck Drugs for Central Nervous System Major Product Offerings
7.8.4 Merck Drugs for Central Nervous System Sales and Revenue in Global (2019-2024)
7.8.5 Merck Key News & Latest Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Company Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Drugs for Central Nervous System Major Product Offerings
7.9.4 AstraZeneca Drugs for Central Nervous System Sales and Revenue in Global (2019-2024)
7.9.5 AstraZeneca Key News & Latest Developments
7.10 Novartis
7.10.1 Novartis Company Summary
7.10.2 Novartis Business Overview
7.10.3 Novartis Drugs for Central Nervous System Major Product Offerings
7.10.4 Novartis Drugs for Central Nervous System Sales and Revenue in Global (2019-2024)
7.10.5 Novartis Key News & Latest Developments
7.11 Takeda
7.11.1 Takeda Company Summary
7.11.2 Takeda Business Overview
7.11.3 Takeda Drugs for Central Nervous System Major Product Offerings
7.11.4 Takeda Drugs for Central Nervous System Sales and Revenue in Global (2019-2024)
7.11.5 Takeda Key News & Latest Developments
8 Global Drugs for Central Nervous System Production Capacity, Analysis
8.1 Global Drugs for Central Nervous System Production Capacity, 2019-2030
8.2 Drugs for Central Nervous System Production Capacity of Key Manufacturers in Global Market
8.3 Global Drugs for Central Nervous System Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Drugs for Central Nervous System Supply Chain Analysis
10.1 Drugs for Central Nervous System Industry Value Chain
10.2 Drugs for Central Nervous System Upstream Market
10.3 Drugs for Central Nervous System Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Drugs for Central Nervous System Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Drugs for Central Nervous System in Global Market
Table 2. Top Drugs for Central Nervous System Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Drugs for Central Nervous System Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Drugs for Central Nervous System Revenue Share by Companies, 2019-2024
Table 5. Global Drugs for Central Nervous System Sales by Companies, (K Units), 2019-2024
Table 6. Global Drugs for Central Nervous System Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Drugs for Central Nervous System Price (2019-2024) & (USD/Unit)
Table 8. Global Manufacturers Drugs for Central Nervous System Product Type
Table 9. List of Global Tier 1 Drugs for Central Nervous System Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Central Nervous System Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Drugs for Central Nervous System Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Drugs for Central Nervous System Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Drugs for Central Nervous System Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Drugs for Central Nervous System Sales (K Units), 2019-2024
Table 15. By Type - Global Drugs for Central Nervous System Sales (K Units), 2025-2030
Table 16. By Application ? Global Drugs for Central Nervous System Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Drugs for Central Nervous System Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Drugs for Central Nervous System Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Drugs for Central Nervous System Sales (K Units), 2019-2024
Table 20. By Application - Global Drugs for Central Nervous System Sales (K Units), 2025-2030
Table 21. By Region ? Global Drugs for Central Nervous System Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Drugs for Central Nervous System Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Drugs for Central Nervous System Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Drugs for Central Nervous System Sales (K Units), 2019-2024
Table 25. By Region - Global Drugs for Central Nervous System Sales (K Units), 2025-2030
Table 26. By Country - North America Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Drugs for Central Nervous System Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Drugs for Central Nervous System Sales, (K Units), 2019-2024
Table 29. By Country - North America Drugs for Central Nervous System Sales, (K Units), 2025-2030
Table 30. By Country - Europe Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Drugs for Central Nervous System Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Drugs for Central Nervous System Sales, (K Units), 2019-2024
Table 33. By Country - Europe Drugs for Central Nervous System Sales, (K Units), 2025-2030
Table 34. By Region - Asia Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Drugs for Central Nervous System Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Drugs for Central Nervous System Sales, (K Units), 2019-2024
Table 37. By Region - Asia Drugs for Central Nervous System Sales, (K Units), 2025-2030
Table 38. By Country - South America Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Drugs for Central Nervous System Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Drugs for Central Nervous System Sales, (K Units), 2019-2024
Table 41. By Country - South America Drugs for Central Nervous System Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Drugs for Central Nervous System Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Drugs for Central Nervous System Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Drugs for Central Nervous System Sales, (K Units), 2025-2030
Table 46. Biogen Company Summary
Table 47. Biogen Drugs for Central Nervous System Product Offerings
Table 48. Biogen Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 49. Biogen Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Drugs for Central Nervous System Product Offerings
Table 52. Pfizer Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 53. Pfizer Key News & Latest Developments
Table 54. Teva Company Summary
Table 55. Teva Drugs for Central Nervous System Product Offerings
Table 56. Teva Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 57. Teva Key News & Latest Developments
Table 58. Novartis Company Summary
Table 59. Novartis Drugs for Central Nervous System Product Offerings
Table 60. Novartis Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 61. Novartis Key News & Latest Developments
Table 62. Johnson & Johnson Company Summary
Table 63. Johnson & Johnson Drugs for Central Nervous System Product Offerings
Table 64. Johnson & Johnson Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 65. Johnson & Johnson Key News & Latest Developments
Table 66. EliLilly Company Summary
Table 67. EliLilly Drugs for Central Nervous System Product Offerings
Table 68. EliLilly Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 69. EliLilly Key News & Latest Developments
Table 70. Otsuka Company Summary
Table 71. Otsuka Drugs for Central Nervous System Product Offerings
Table 72. Otsuka Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 73. Otsuka Key News & Latest Developments
Table 74. Merck Company Summary
Table 75. Merck Drugs for Central Nervous System Product Offerings
Table 76. Merck Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 77. Merck Key News & Latest Developments
Table 78. AstraZeneca Company Summary
Table 79. AstraZeneca Drugs for Central Nervous System Product Offerings
Table 80. AstraZeneca Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 81. AstraZeneca Key News & Latest Developments
Table 82. Novartis Company Summary
Table 83. Novartis Drugs for Central Nervous System Product Offerings
Table 84. Novartis Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 85. Novartis Key News & Latest Developments
Table 86. Takeda Company Summary
Table 87. Takeda Drugs for Central Nervous System Product Offerings
Table 88. Takeda Drugs for Central Nervous System Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2019-2024)
Table 89. Takeda Key News & Latest Developments
Table 90. Drugs for Central Nervous System Production Capacity (K Units) of Key Manufacturers in Global Market, 2022-2024 (K Units)
Table 91. Global Drugs for Central Nervous System Capacity Market Share of Key Manufacturers, 2022-2024
Table 92. Global Drugs for Central Nervous System Production by Region, 2019-2024 (K Units)
Table 93. Global Drugs for Central Nervous System Production by Region, 2025-2030 (K Units)
Table 94. Drugs for Central Nervous System Market Opportunities & Trends in Global Market
Table 95. Drugs for Central Nervous System Market Drivers in Global Market
Table 96. Drugs for Central Nervous System Market Restraints in Global Market
Table 97. Drugs for Central Nervous System Raw Materials
Table 98. Drugs for Central Nervous System Raw Materials Suppliers in Global Market
Table 99. Typical Drugs for Central Nervous System Downstream
Table 100. Drugs for Central Nervous System Downstream Clients in Global Market
Table 101. Drugs for Central Nervous System Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Drugs for Central Nervous System Segment by Type in 2023
Figure 2. Drugs for Central Nervous System Segment by Application in 2023
Figure 3. Global Drugs for Central Nervous System Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Drugs for Central Nervous System Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Drugs for Central Nervous System Revenue, 2019-2030 (US$, Mn)
Figure 7. Drugs for Central Nervous System Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Drugs for Central Nervous System Revenue in 2023
Figure 9. By Type - Global Drugs for Central Nervous System Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Drugs for Central Nervous System Revenue Market Share, 2019-2030
Figure 11. By Type - Global Drugs for Central Nervous System Sales Market Share, 2019-2030
Figure 12. By Type - Global Drugs for Central Nervous System Price (USD/Unit), 2019-2030
Figure 13. By Application - Global Drugs for Central Nervous System Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Drugs for Central Nervous System Revenue Market Share, 2019-2030
Figure 15. By Application - Global Drugs for Central Nervous System Sales Market Share, 2019-2030
Figure 16. By Application - Global Drugs for Central Nervous System Price (USD/Unit), 2019-2030
Figure 17. By Region - Global Drugs for Central Nervous System Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Drugs for Central Nervous System Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Drugs for Central Nervous System Revenue Market Share, 2019-2030
Figure 20. By Region - Global Drugs for Central Nervous System Sales Market Share, 2019-2030
Figure 21. By Country - North America Drugs for Central Nervous System Revenue Market Share, 2019-2030
Figure 22. By Country - North America Drugs for Central Nervous System Sales Market Share, 2019-2030
Figure 23. US Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Drugs for Central Nervous System Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Drugs for Central Nervous System Sales Market Share, 2019-2030
Figure 28. Germany Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 29. France Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Drugs for Central Nervous System Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Drugs for Central Nervous System Sales Market Share, 2019-2030
Figure 37. China Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 41. India Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Drugs for Central Nervous System Revenue Market Share, 2019-2030
Figure 43. By Country - South America Drugs for Central Nervous System Sales Market Share, 2019-2030
Figure 44. Brazil Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Drugs for Central Nervous System Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Drugs for Central Nervous System Sales Market Share, 2019-2030
Figure 48. Turkey Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Drugs for Central Nervous System Revenue, (US$, Mn), 2019-2030
Figure 52. Global Drugs for Central Nervous System Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Drugs for Central Nervous System by Region, 2023 VS 2030
Figure 54. Drugs for Central Nervous System Industry Value Chain
Figure 55. Marketing Channels
